| Literature DB >> 33318564 |
Rieke Fruengel1, Timo Bröhl1,2, Thorsten Rings1,2, Klaus Lehnertz3,4,5.
Abstract
Previous research has indicated that temporal changes of centrality of specific nodes in human evolving large-scale epileptic brain networks carry information predictive of impending seizures. Centrality is a fundamental network-theoretical concept that allows one to assess the role a node plays in a network. This concept allows for various interpretations, which is reflected in a number of centrality indices. Here we aim to achieve a more general understanding of local and global network reconfigurations during the pre-seizure period as indicated by changes of different node centrality indices. To this end, we investigate-in a time-resolved manner-evolving large-scale epileptic brain networks that we derived from multi-day, multi-electrode intracranial electroencephalograpic recordings from a large but inhomogeneous group of subjects with pharmacoresistant epilepsies with different anatomical origins. We estimate multiple centrality indices to assess the various roles the nodes play while the networks transit from the seizure-free to the pre-seizure period. Our findings allow us to formulate several major scenarios for the reconfiguration of an evolving epileptic brain network prior to seizures, which indicate that there is likely not a single network mechanism underlying seizure generation. Rather, local and global aspects of the pre-seizure network reconfiguration affect virtually all network constituents, from the various brain regions to the functional connections between them.Entities:
Mesh:
Year: 2020 PMID: 33318564 PMCID: PMC7736584 DOI: 10.1038/s41598-020-78899-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Relative pre-seizure change of centrality values of nodes in the different modules. Non-hatched/hatched bars represent median values over predictive/non-predictive nodes (median pre-seizure centrality values referenced against median centrality values from seizure-free periods). Blue/black numbers on top represent the number of predictive/non-predictive nodes in each module ( strength centrality; betweenness centrality; closeness centrality; eigenvector centrality; “total” refers to the sum of these nodes). As betweenness centrality often yields values of 0, calculating a relative difference is not always possible, therefore we refer to the median absolute value which here amounts to 0.005 independent of the module (SOZ: , neighbours: , others: ).
Figure 2Predictive nodes as identified with only respective centralities or combinations of such. For example, there are 13 nodes identified as predictive with , that are not identified as predictive with the other three centralities, and 4 nodes identified as predictive with and , that are not identified as predictive with the other two centralities. Different colours indicate different centralities (light blue: strength centrality ; dark blue: eigenvector centrality ; light red: closeness centrality ; dark red: betweenness centrality ). Centrality indices considering local/global aspects of the evolving epileptic brain network are depicted in light/dark colour respectively, while strength-/path-based centrality indices are depicted in blue/red. Hatched bars indicate a combination of the respective centralities (see colours above).
Figure 3Scenarios for the pre-seizure reconfiguration of the evolving epileptic brain network. Schematic of the network divided into the three functional modules (others , neighbours , SOZ ; separated by dashed lines). The different sub-figures (a–f) represent how the network during the seizure-free period (top) would change prior to seizures if the pink nodes were deemed predictive with the respective local and global interaction-strength-based and path-based centrality indices or combinations thereof (note that different centrality indices generally identified different nodes as predictive; we here restrict ourselves to just a few nodes to simplify visualisation). The networks can be assumed to be fully connected, however, for the purpose of visualisation, edges that remain unchanged during seizure-free and pre-seizure periods are not shown. Shortest paths identified in the seizure-free period (examples) are marked green. The thickness of an edge represents its edge weight: the thicker an edge the shorter the path traversing the edge or the stronger the connection between nodes. (: strength centrality; eigenvector centrality; closeness centrality; : betweenness centrality).
Subject demographics. Age age at time of presurgical evaluation, Dur duration of epilepsy in years, MRI MRI findings (w.p.f. without pathological findings, AHS Ammon’s horn sclerosis, bilat. bilateral, FCD focal cortical dysplasia), L left, R right, Loc location of seizure onset zone (MT mesial temporal, SMA supplementary motor area, P parietal, F frontal, Fpo frontopolar, Fpa frontoparietal, FT frontotemporal, T temporal), Out epilepsy surgery outcome scale [48] (no surgery performed if empty entry), Szr number of clinical seizures; total recording duration in hours, total duration of seizure-free periods in hours, total duration of pre-seizure periods in hours; N total number of electrode contacts, number of electrode contacts in functional module “SOZ”; number of electrode contacts in functional module “neighbours”, number of electrode contacts in functional module “others”, number of centralities that identified predictive nodes.
| Subj. | Age | Sex | Dur | MRI | Loc | Out | Szr | D | D | D | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 54 | Male | 46 | R AHS | RMT | 2B | 1 | 228 | 224 | 4 | 86 | 3 | 2 | 81 | 0 |
| 2 | 34 | Male | 29 | L FCD | LF | 1A | 7 | 111 | 85 | 26 | 26 | 5 | 5 | 16 | 4 |
| 3 | 15 | Female | 10 | R AHS | LT,RT | 4 | 162 | 146 | 16 | 66 | 44 | 0 | 22 | 0 | |
| 4 | 45 | Female | 42 | L AHS | LT | 1A | 1 | 146 | 142 | 4 | 48 | 12 | 2 | 34 | 0 |
| 5 | 25 | Female | 21 | w.p.f. | RMT | 1A | 1 | 82 | 78 | 4 | 58 | 10 | 1 | 47 | 0 |
| 6 | 22 | Male | 23 | w.p.f. | RMT | 1A | 5 | 94 | 74 | 20 | 74 | 10 | 1 | 63 | 0 |
| 7 | 57 | Male | 51 | Hamartia | RFPo | 1A | 3 | 71 | 61 | 10 | 72 | 14 | 11 | 47 | 3 |
| 8 | 39 | Female | 11 | R AHS | RT | 1A | 3 | 91 | 79 | 12 | 52 | 11 | 3 | 38 | 0 |
| 9 | 24 | Female | 23 | AHS bilat. | LMT,RMT | 2 | 20 | 14 | 6 | 42 | 20 | 0 | 22 | 1 | |
| 10 | 34 | Male | 33 | L AHS, L FCD | LMT | 1A | 4 | 70 | 54 | 16 | 52 | 20 | 4 | 28 | 0 |
| 11 | 25 | Male | 24 | L AHS | LMT | 1A | 3 | 26 | 17 | 9 | 58 | 3 | 5 | 50 | 0 |
| 12 | 43 | Female | 27 | w.p.f. | LT | 1A | 3 | 94 | 85 | 9 | 56 | 8 | 0 | 48 | 4 |
| 13 | 29 | Male | 17 | L AHS | LMT,RMT | 4 | 92 | 76 | 16 | 120 | 20 | 4 | 96 | 1 | |
| 14 | 38 | Male | 15 | AHS bilat. | LMT | 1A | 2 | 52 | 44 | 8 | 46 | 8 | 4 | 34 | 0 |
| 15 | 44 | Female | 31 | L FCD | LF | 1A | 1 | 103 | 99 | 4 | 14 | 4 | 0 | 10 | 0 |
| 16 | 52 | Male | 52 | L AHS | LMT | 1A | 1 | 49 | 45 | 4 | 42 | 5 | 4 | 33 | 3 |
| 17 | 45 | Male | 24 | w.p.f. | LT,RT | 3 | 116 | 107 | 9 | 72 | 28 | 0 | 44 | 2 | |
| 18 | 31 | Female | 14 | w.p.f. | RT | 1A | 2 | 74 | 69 | 5 | 36 | 11 | 1 | 24 | 3 |
| 19 | 25 | Female | 6 | w.p.f. | LMT,RMT | 5 | 161 | 142 | 19 | 90 | 8 | 1 | 81 | 4 | |
| 20 | 53 | Female | 13 | L AHS | LP | 1A | 1 | 46 | 42 | 4 | 24 | 11 | 3 | 10 | 0 |
| 21 | 62 | Female | 50 | Dysplasia | RFPa | 3 | 94 | 84 | 10 | 56 | 39 | 1 | 16 | 2 | |
| 22 | 44 | Female | 30 | L AHS | LT,RT | 1A | 3 | 129 | 117 | 12 | 46 | 30 | 0 | 16 | 2 |
| 23 | 25 | Male | 13 | R FCD | RFP | 1A | 3 | 18 | 8 | 10 | 30 | 5 | 4 | 21 | 2 |
| 24 | 26 | Female | 10 | Dysplasia | LT | 1A | 1 | 26 | 22 | 4 | 16 | 5 | 4 | 7 | 1 |
| 25 | 54 | Female | 49 | R FCD | RT | 1A | 1 | 67 | 63 | 4 | 62 | 9 | 7 | 46 | 0 |
| 26 | 27 | Female | 16 | w.p.f. | LMT | 1A | 2 | 163 | 155 | 8 | 48 | 10 | 2 | 36 | 4 |
| 27 | 28 | Female | 25 | R AHS | LMT,RMT | 2 | 126 | 121 | 5 | 46 | 21 | 1 | 24 | 0 | |
| 28 | 19 | Male | 9 | AHS bilat. | LFT,RFT | 2 | 47 | 40 | 7 | 78 | 34 | 2 | 42 | 2 | |
| 29 | 26 | Female | 18 | w.p.f. | LMT | 2A | 3 | 97 | 85 | 12 | 36 | 10 | 0 | 26 | 1 |
| 30 | 37 | Male | 5 | R AHS | RMT | 1A | 2 | 103 | 95 | 8 | 46 | 10 | 4 | 32 | 4 |
| 31 | 25 | Male | 26 | L AHS | LFT,RFT | 2 | 32 | 25 | 7 | 78 | 0 | 0 | 78 | 0 | |
| 32 | 37 | Male | 2 | w.p.f. | LMT | 1A | 4 | 68 | 52 | 16 | 65 | 6 | 0 | 59 | 2 |
| 33 | 15 | Female | 11 | L FCD | LFPo | 1A | 2 | 36 | 28 | 8 | 30 | 8 | 7 | 15 | 1 |
| 34 | 24 | Male | 4 | w.p.f. | LMT | 1A | 2 | 67 | 59 | 8 | 65 | 6 | 3 | 56 | 4 |
| 35 | 22 | Male | 18 | Lesion | LFT | 1A | 3 | 19 | 7 | 12 | 38 | 4 | 2 | 32 | 2 |
| 36 | 29 | Female | 12 | w.p.f. | LMT,RMT | 2 | 37 | 29 | 8 | 88 | 6 | 1 | 81 | 3 | |
| 37 | 41 | Female | 13 | w.p.f. | LMT,RM | 2 | 127 | 119 | 8 | 118 | 13 | 5 | 100 | 4 | |
| 38 | 27 | Female | 13 | L FCD | LSMA | 1A | 2 | 67 | 59 | 8 | 30 | 6 | 7 | 17 | 0 |